National recruitment firm Slone Partners is pleased to announce it will be a corporate sponsor for the 23rd International Molecular Med TRI-CON, the largest annual networking event attended by the world’s most influential diagnostics experts.
As a specialty recruitment firm for the diagnostics, life science tools, healthcare information technology and laboratory testing industries, Slone Partners contributes to the advancement of the diagnostics space by developing, for its clients, teams who are composed of amazing talent.
“The genomics space is showing tremendous growth and, as a result, competition for talent has greatly increased. For companies who are developing a team in diagnostics, or NGS, it is now more important than ever to have access to the best talent. We, at Slone Partners, are in constant dialogue with the leaders of the industry. Our team is committed to providing the companies represented at TRI-CON the talent required to surpass their objectives,” said Adam Slone, CEO of Slone Partners.
This year’s Tri-Conference is projected to attract over 3,300 diagnostics experts from over 40 countries. The event’s focus is on molecular medicine, specifically on discovery, genomics, diagnostics and information technology. In 2016, it has expanded its coverage to include additional programs on molecular diagnostics for infectious disease, precision medicine and cancer immunotherapy.
The 23rd Annual Molecular Med TRI-CON will be held March 6-11, 2016 at the Moscone North Convention Center in San Francisco. To learn more, visit http://www.triconference.com.
About Slone Partners:
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the diagnostics, life science tools, healthcare information technology and laboratory testing industries. Slone Partners has offices in Boston, New York, Washington, D.C. and San Francisco.
Press release edited on 6/28/2023